Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @RoyalPapLib
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RoyalPapLib
-
Prikvačeni tweet
We're very excited that our first impact case study has been approved. Congratulations to Becky Scott
@the_bookette on her brilliant work.#amilliondecisions@RoyalPapRes@papworthcharity@papworth_pd@PapworthAHPs@PapworthPhysio@PapCriticalCare@PapworthSALThttps://twitter.com/RoyalPapworth/status/1182665224727470083 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great chance to see the inside of the
@RoyalPapworth . Book your tour now. Part of@camscience Festival 2020https://twitter.com/RoyalPapworth/status/1224664098509611009 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: Familial pulmonary arterial hypertension by KDR heterozygous loss of function. https://buff.ly/2RS3IOd .#PAH#pulmonaryArterialHypertension#KDRgenepic.twitter.com/w25ZXfd4AA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: Low Pulmonary Artery Pulsatility Index Is Associated with Adverse Outcomes in Ambulatory Patients with Advanced Heart Failure. https://buff.ly/2u5TWiN .#HeartFailure#heartTransplant;#PAPi#RightHeartCatheterization@drstephenpettitpic.twitter.com/kBwuyDVmzt
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Royal Papworth Hospital Library proslijedio/la je Tweet
Bookings open for the
@camscience Festival 2020 next week
We’re offering the chance to see inside our hospital and meet some of our outstanding teams on one of our tours.
Sunday 22 March
11:00-16:00
Full details can be found at http://www.sciencefestival.cam.ac.uk pic.twitter.com/z96p1KNgWH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Royal Papworth Hospital Library proslijedio/la je Tweet
Diagnosing lung cancer at an early stage can lead to more treatment options and better outcomes for patients. Read our new report Early Diagnosis Matters here http://www.uklcc.org.uk and help us save more lives.pic.twitter.com/QVvyocpSFK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: Long-term outcome of critical aortic valve stenosis. https://buff.ly/2U3lpw4 .#criticalAorticValveStenosis#CASpic.twitter.com/bsUquq2f9k
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: Mechanism of Recurrence of AT: Comparison between First Vs. Redo Procedures in a High-resolution Mapping System. https://buff.ly/2U1QxMg .#atrialFibrillation#CatheterAblation#AtrialTachycardiapic.twitter.com/Mv4suHqnP1
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma. https://buff.ly/2TYjSY5 .#esophagealAdenocarcinoma#EAC#ClonalDiasporapic.twitter.com/uY1SpssNJg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: Maintaining the permanence principle for death during in situ normothermic regional perfusion for donation after circulatory death organ recovery: A United Kingdom and Canadian proposal. https://buff.ly/37Ah2w6 .#DCD#ECMO)#OrganPerfusion#OApic.twitter.com/RCVyc0szx4
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: Long-term safety, tolerability and efficacy of macitentan in patients with inoperable chronic thromboembolic pulmonary hypertension: The merit-1 study and its open-label extension merit-2. https://buff.ly/2U8Zwvn#CTEPH#macitentanHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: Safety of riociguat for the treatment of pulmonary arterial hypertension: Final data cut from the expert registry. https://buff.ly/30ZJp4x .#pulmonaryArterialHypertension#PAH#riociguatHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: Safety of riociguat for the treatment of chronic thromboembolic pulmonary hypertension: Final data cut from the expert registry. https://buff.ly/2sROnDJ .#chronicThromboembolicPulmonaryHypertension#CTEPH#riociguatHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
World-first surgery
@RoyalPapworth. Can you imagine how many hours of research would have gone into it? Remember that Library Services are here to assist with literature searches, journal articles and much more.@RoyalPapRes@PapworthSALT@RPH_RespPhyshttps://www.telegraph.co.uk/news/2020/01/26/retired-milkmans-entire-lung-removed-keyhole-surgery-world-first/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: European Association of Cardiothoracic Anesthesiology (EACTA) Cardiothoracic and Vascular Anesthesia Fellowship Curriculum: First Edition. https://buff.ly/2tDPvLQ .#anesthesiaFellowship#EACTA#CTVApic.twitter.com/mhRIwXt7wj
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: Estrogen imbalance in patients with pulmonary arterial hypertension: Profiling metabolites using LC-MS/MS. https://buff.ly/38LJOdJ .#PulmonaryArterialHypertension#EstrogenImbalance#PAHpic.twitter.com/AGdLEeQ7UV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: Rationale and design of the selexipag in inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension (SELECT) trial. https://buff.ly/3aDpBsb .#ChronicThromboembolicPulmonaryHypertension#CTEPH#selexipagpic.twitter.com/chh8rpreVB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: Inhaled ciprofloxacin (ARD-3150) in patients with non-cystic fibrosis bronchiectasis and frequent pulmonary exacerbations: A pooled analysis from orbit-3 and orbit-4. https://buff.ly/38BVXBQ#bronchiectasis#pulmonaryExacerbation#ciprofloxacinpic.twitter.com/D5VuXSWQOC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#papworthauthors new publication: A multicentre study of anticoagulation in operable chronic thromboembolic pulmonary hypertension. https://buff.ly/3axr2s8 .#chronicThromboembolicPulmonaryHypertension#CTEPH#PEA#anticoagulationpic.twitter.com/zaK9YgmGUg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Royal Papworth Hospital Library proslijedio/la je Tweet
#AHPs Midlands & East. Want to keep up to date with all things AHP related from@NHS_HealthEdEng? Then please join our AHP network by clicking on this link. Thank you. https://healtheducationyh.onlinesurveys.ac.uk/me-ahpHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Royal Papworth Hospital Library proslijedio/la je Tweet
Thinking of fundraising for us but not sure how you're going to do it? Well now you can take fundraising inspiration from some of our current community and events fundraisers!



Our fundraisers:https://www.papworthhospitalcharity.org.uk/our-fundraisers Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.